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A number of hypotheses have been offered in explanation of the mode of 
action of sulfanilamide and allied compounds (1-8).  However, the prob- 
lem is  so  complex that  no one hypothesis is  in  itself satisfactory.  Our 
studies have indicated that one of the important rSles of these compounds 
is their effect on the metabolism of the bacterial cell.  In trying to define 
this  effect more closely, we  have  investigated the  relationships between 
these drugs, growth substances, and the multiplication of microorganisms. 
The purpose of this paper is to present observations on some of these rela- 
tionships which represent one facet of a  many sided problem. 
Preliminary  observations  showed  that  effective bacteriostasis by  sulf- 
anilamide was not a result of its changing the culture medium.  Effective- 
ness  appeared  dependent  on  its  modifying  the  bacterium.  Hemolytic 
streptococcus grown in sulfanilamide or in sulfapyridine for 6 hours and 
then washed until the supernatant fluid was free of drug was unable to 
multiply in normal manner on transplantation to broth containing the same 
compound.  This was less striking when the incubation was for 4 hours and 
still less when for only 2 hours.  These observations were in accord with 
those of Chandler and Janeway  (9).  All of our evidence indicated that 
organisms were modified by adequate concentrations of the drug.  How- 
ever, existing methods were not sufficiently delicate to detect any disap- 
pearance  of  the  drug  from  the  medium.  Crossley  (10)  meanwhile has 
demonstrated that a  small amount of the drug combines with the micro- 
organism and that the combination cannot be broken by repeated washings. 
The union of drug and microorganisms is unfavorable to the growth of 
the bacterium.  However, this adverse effect is not necessarily a permanent 
one.  Organisms which survived for 16 hours or longer in sulfanilamide or 
sulfapyridine showed rapid growth on transplantation to media containing 
these drugs.  As seen in Fig. 1, organisms which survived for over 16 hours 
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in sulfanilamide multiplied almost as rapidly in sulfanilamide broth as in 
normal broth.  These organisms had become "fast."  This development 
suggested that variation might be 
'  '  '  '  '  '  possible in a  bacterial enzyme sys- 
zo  f  -  :  :"  tem whereby  the organisms, tem- 
i.s  .  porarily incapacitated by the drug, 
1.0  o"  ~,°"  could adapt themselves to the new 
.$  ~..~°~  4hour incuba#ion  environment.  The  concept  that 
sulfonamides may affect a bacterial 
t.s  /  ....  enzyme system conforms with one 
,.o  /  -  of  the  striking  characteristics  of 
•  ~  the  action  of  the  drug in vitro-- 
ds" 6hour  that is, the lag.  As Chandler and 
"~zo  .  ,  :  :  .  Janeway  (9)  and  Mclntosh  and 
8t.s~  /  .  Whitby  (11)  have  pointed  out, 
~_.li:~ /  tp...-  "  growth occurs normally for at least 
/SShour incul~tion  5  hours  in  the  presence of these 
__.d t  compounds.  In  striking  contrast 
~l.s~,  .--  ,=.  to  the  germicides,  sulfanilamide 
~ti:~/"  ~/~.  ,.~'/,ho,r'""  does not modify the growth curve 
-  /mutation  until  6  hours  after  inoculation. 
w__..-  "  This  failure  of  sulfanilamide  to 
z0[  /.,-~'"  :  ............  show a  bactericidal effect before 6 
t.s~F/fir  hours suggested that certain essen- 
~  tial  requirements  for  bacterial 
I.o  s  ,.~4/Tovr  incubs~'/on  growth might be supplied initially 
.s  by intracellular sources, as did the 
|  I  I  I  i  I 
z  •  6  s  tz  2o  fact  that  the  addition  of  cellular 
"="  Plain bro'l'h  Hours  debris (12, 13)  to the medium nul- 
....  $ul'fanilamid¢  b~o¢h  lifted the  bacteriostatic  effects  of 
FIG.  1.  Growth of Streptococcus  hemoly-  these drugs.  Similarly, Stamp (14) 
titus with and without sulfanilamide  follow-  has clearly shown that a fraction of 
ing preliminary incubation in sulfanilamide 
broth for  various periods of time (4 to 24  a  broth culture of hemolytic strep- 
hours),  tococcus antagonizes the bacterio- 
static action of  sulfanilamide and 
suggested that this fraction may contain a necessary nutritive factor against 
which the drug is active.  Recently Green  (15)  has  described  a  growth- 
stimulating antisulfanilamide factor obtained from Brucella abortus.  He 
feels that his "P"  factor may stimulate the same enzyme reaction in the 
bacterial  cell  which  sulfanilamide  inhibits.  Finally,  Woods  (16)  has RANDOLPH  WEST  AND  ALVIN  1%  COBURN  93 
observed that  p-aminobenzoic  acid  neutralizes  the  bacteriostatic  effect of 
sulfanilamide. 
The fact that  nicotinic  acid  amide  and  sulfanilamide  and  sulfapyridine 
contain  certain  similar  chemical  groupings,  the  appearance  of  porphyri- 
nuria  on  adding  sulfonamide  compounds  to  (17)  or withdrawing  nicotinic 
acid  from the  diet  (18),  and  the  inhibition  by sulfapyridine  of lactic and 
pyruvic acid dehydrogenase (19, 20) in the pneumococcus all suggested that 
sulfapyridine may inhibit the synthesis or proper  functioning  of  coenzyme 
I  or II.  It therefore seemed advisable to study the effect of sulfapyridine, 
nicotinic acid, and  coenzymes on an organism for which nicotinic acid was 
essential for growth. 
Materials 
Medium.--The basal medium was  made of Nelson's photographic gelatin  No.  1, 
imported from England  by the  Eastman  Kodak  Company.  Care  was  exercised  to 
remove all  traces  of  barium  from the  hydrolysate.  The  medium  was  sterilized  by 
autoclaving.  Knight's  procedure  (21) was followed  throughout,  with  the  exception 
that thiamine was not used. 
Organism.--A  strain of hemolytic Staphylococcus aureus recently isolated from the 
throat was employed. 
Chemicals.--Nicotinic acid was obtained from the Eastman Kodak Company, the 
sodium salt of sulfapyridine and highly purified yeast coenzymes (A Co value 132,300) 
from Merck and Company. 
Crude coenzymes were prepared by centrifuging citrated normal human blood (22), 
discarding  the  plasma, diluting  the  packed red  cells  with  three  volumes of distilled 
water, heating on a boiling water bath until the proteins were coagulated, and filtering. 
The filtrate was then adjusted to pH 4.7 with N/1 hydrochloric acid, again heated, and 
a  second small coagulum removed by filtration.  Half of the extract was adjusted  to 
pH 6.5 with N/1 NaOH and sterilized by boiling on the water bath for a few minutes; 
the other half was adjusted to pH 10 (just blue to thymol blue) and autoclaved at 120°C. 
for 30 minutes to destroy coenzymes. 
The highly purified yeast coenzymes were dissolved in water and half of the solution 
was sterilized for 10 minutes in a boiling water bath; the other half inactivated by auto- 
claving as described above, a  little Na2HPO4 being used instead of NaOH.  Plasma 
extracts were prepared exactly as were red cell extracts. 
All  water used was triple  distilled,  and all glassware,  including  pipettes and  test 
tubes,  were cleaned with bichromate sulfuric acid cleaning  fluid,  washed  thoroughly 
with triple distilled water, and sterilized by autoclaving.  Nicotinic acid and sodium 
sulfapyridine were sterilized by passing through a  Seitz filter. 
Procedure 
All tubes containing 10 cc. of basal medium were inoculated from a 24 hour culture 
grown on an agar slant.  A heavy suspension  of organisms was diluted until the final 
suspension  contained less than 1,000 colonies per cc.  Clouding  of the medium, plating 94  GROWTH  OF  STAPHYLOCOCCUS AU-REUS 
with a wire loop, and pour plating when indicated were used to observe growth.  Incuba- 
tion was at 37°C. for 48 hours.  When the colonies were too numerous to count,  they 
are recorded as  +  to  +  +  +  +.  The numbers in the tables indicate the colonies per 
cc. of Knight's medium. 
RESULTS 
Effect on Growth Curve of Nicotinic Acid Added to Basal Medium 
Table I  shows that the organism was unable to multiply on the basal 
medium until nicotinic acid was added, confirming Knight (21). 
TABLE  I 
O2_ZL  lo  1_)_2  1_2_   1__ o __ 
~asal  medium ......................  I 614130~118811051 1111  1241  1251  107 
B.~  O.lcc.  /lOO nicotinic .........  672 248 208 198  +  ++  I+--k+ ++++ 
BasalO.lcc.  M/1,OOOnicotinic ........  11181181321191 831 5,5161 5,120[  + 
24 
278 
++++ 
+++ 
TABLE  II 
Hours  Basal  Nicotinic 
__medium  acid~K/l,00f 
C¢.  CG. 
10  0.1 
i0  0.1 
10  0.1 
10  0.1 
Sulfapyri- 
~line M  / I ,000 
r,#° 
0 
0.15 
0 
0.15 
.....  24  0  14  16  18  20 
74  I  3,°°°126,°°°13°,°°°1  +  I  ++ 
I  O  l  lOl  lOl  11o  I  o 
09  I  17,°°°  I  3°,°°°  I  72,°°°  F  ++  I++++ 
148  [  o  I  o]  o  I  o  I  o 
Effect  of Sulfapyridine  and  Nicotinic Acid  on  Growth  Curve  in  Basal 
Medium 
This  experiment was  designed to  determine whether sulfapyridine ex- 
erted its bacteriostatic effect in the presence of nicotinic acid.  The results 
of two typical experiments axe presented in Table II. 
It is seen that the bacteriostafic action of sulfapyridine is exerted in the 
presence of nicotinic acid, under these experimental conditions. 
Effect of Sulfapyridine and Red Blood Cell Extract on Growth Curve in Basal 
Medium 
Since the bacteriostatic effect of sulfapyridine was not inhibited by free 
nicotinic acid, the effect of nicotinic acid chemically combined as coenzymes 
was next investigated.  As a  convenient source of coenzymes, human red 
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The  red  cell  extract  as made  was of such  a  concentration  that  1.5  cc. 
had  to be added  to  each  tube of basal medium  to  correspond to 0.15  cc. 
of 3/1,000  coenzyme solution  (22).  It  is  recorded  in  the  latter  way in 
Table III in order to conform to the other tables. 
The  sulfapyridine  failed  to  inhibit  growth  in  the  presence  of  active 
red cell extract, but was effective in doing so in the presence of autoclaved 
extract.  Since coenzymes are present in red cell extract and are  destroyed 
by  autoclaving  in  weak  alkali,  we  investigated  the  possibility  that  this 
effect was due to  coenzymes. 
TABLE  III 
Basal 
medium 
CC. 
10 
10 
10 
10 
Active  red 
cell extract 
~/1,000 
6C. 
0.15 
0.15 
0 
0 
Inactive 
autoclaved 
red cell ex- 
tract • t/l,O00 
cG. 
0 
0 
0.15 
0.15 
Sulfapyridine 
M/I,O00 
6t:. 
0.10 
0.10 
0.10 
0.10 
Hours 
0  14  16  18  20 
106  .4-  +  +-t-++  -4--{-++ 
115  ±  +  ++++  ~ ++++ 
73  o  o  o  !  o 
90  0  0  0  i  0 
24 
++++ 
++++ 
0 
0 
Effect of Sulfapyridine and Blood Plasma Extract on Growth Curve in Basal 
Medium 
As plasma does not contain  coenzymes, an extract was prepared similar 
to  that  made  from  red  blood ceils.  Our  experiments  showed that  these 
extracts also inhibited the bacteriostatic effect of sulfapyridine.  However, 
the  inhibition  persisted  when  extracts  autoclaved  at  pH  10  were  used. 
This was in sharp  contrast to the red cell extract  and suggested that  sub- 
stances  other  than  coenzymes were  responsible for  the  effect.  Since  the 
results  with  the  plasma  extracts  were  not  always  constant,  tables  are 
omitted. 
Effect of Sulfapyridine  and Crude  Yeast Extract  on Growth Curve in Basal 
Medium 
As yeast is a rich source of coenzymes, a crude extract of pressed bakers' 
yeast was prepared by the same methods used in making the red blood cell 
extracts.  The  crude yeast extracts,  both fresh  and  autoclaved, inhibited 
the  bacteriostatic  effect of  the  sulfapyridine,  suggesting  that  there  were 
other  substances in  addition  to coenzymes responsible for this  inhibition. 
These yeast extracts, though rich in coenzymes, were not sufficiently puri- 
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Effect of Sulfapyridine and Highly Purified Yeast Coenzymes on Growt& 
Curve in Basal Medium 
As the preceding experiment indicated that crude yeast extract contained 
interfering substances, it was repeated with highly purified yeast coenzymes 
(A Co value 132,300).  Colony counts were not done in this experiment. 
The tubes were inoculated, clouding observed, and streak cultures made on 
blood agar plates after 24 and 48 hours are recorded in Table IV. 
The highly purified yeast coenzymes inhibit the bacteriostatic effect of 
sulfapyridine, while the autoclaved control does not do so. 
TABLE  IV 
Basal medium 
10 
10 
Sulfapyridlne 
M/10 
CG. 
0.I 
0.1 
Active coenzymes 
M/500 
CG. 
0.2 
0 
Inactive autoclave~ 
coenzymes K/500 
CO. 
0 
0.2 
Hours 
+++  ++++ 
0 
DISCUSSION 
It is evident that substances other than coenzymes inhibit the bacterio- 
static effect of sulfapyridine.  Our observations show that, under the con- 
ditions of these experiments, coenzyme interferes with the bacteriostatic 
action  of  sulfapyridine; whereas  nicotinic acid  fails  to  have  this effect. 
A possible explanation is that sulfapyridine and nicotinic acid compete for 
the  same position in  the  coenzyme molecule.  Given nicotinic acid,  the 
organism on  the  basal  medium is  presumably  able  to  form  coenzymes 
(nicotinic acid amide adenine dinucleotide).  However, given nicotinic acid 
and sulfapyridine, the organism may be unable to form coenzymes or the 
activity  of  certain  dehydrogenases  (coenzymes combined with  protein) 
may be inhibited.  When preformed coenzymes are present in the medium, 
the normal metabolism of the organism is not modified by sulfapyridine and 
the customary growth curve is seen.  As all cultures were aerobic, it seems 
improbable that  coenzymes functioned merely as  reducing agents. 
SUMMARY 
Our studies indicate that sulfapyridine modifies the normal metabolism 
of a  bacterium. 
Coenzymes inhibit the effect of sulfapyridine on the growth of staphylo- 
coccus in Knight's medium. RANDOLPH WEST AND  ALVIN F.  COBURN  97 
Nicotinic acid does not interfere with the action of sulfapyridine under 
the same conditions. 
The possible relation of sulfapyridine, nicotinic acid, and coenzymes in 
relation to  bacterial growth is discussed. 
We are indebted to Dr. R. T. Major of Merck and Company for supplying us gener- 
ously with cozymase. 
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